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training routine NF1 healthcare can be led by an ANP. The clinical
benefits of subspecialisation are an increasing ability to recognise
NF1-related problems, particularly the learning and behaviour issues
but also to distinguish severe from mild NF1 phenotypes. For the
families the advantage is that the ANP can see the children at
home/school or clinic and knows when to encourage affected
parents to seek review. The ANP and NF1 specialist hold a 6-
monthly clinic in Bolton for all ages.
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Objectives: Parents are expected to contribute to the expert/
medical management of chronic disease in their children in many
ways, including medication administration, feeding regimens,
injections and home dialysis at the same time as being ‘‘normal’’
parents. Their involvement is well documented to be very
important and the quality of it may affect the clinical outcome.
Since previous research has focussed on mothers as the main
respondents, fathers’ views are underrepresented. Our objective was
to explore/compare parents’ individual and joint accounts of their
contributions to care.
Methods: As this was a previously unexplored area of clinical
practice, a qualitative design based on the principles of grounded
theory was used. Parents were selected from one UK children’s
kidney unit using a purposive sampling approach based on their
child’s age, gender and level of clinical intervention needed. Mothers
and fathers of 59 children each received postal invitations to
participate. Confidentiality and anonymity were assured. The
resulting sample involved 14 couples (the parents of 15 children
with a long-term kidney condition) who represented a range of
educational backgrounds, social circumstances and occupations.
Data were obtained through 28 individual and 14 joint, semistruc-
tured interviews, tape-recorded/transcribed/analysed using a pro-
cess of constant comparison. Individual and joint datasets were
compared and contrasted.
Results: Parents generally shared the management role but had
different ways of coping with this. Analysis revealed five themes
that we called: Developing skills; Impact of the condition on daily
life; Mutual support; Coping and Things that help. Emotional/
physiological effects were reported by some when managing care at
home (even parents who were health professionals). Fathers
sometimes coped by ‘‘disengaging’’ from the situation, they needed
to understand the ‘‘bigger picture’’, what might happen in the
future and be reassured that professionals ‘‘know what they are
doing’’. Mothers’ coping was facilitated by remaining close to the
situation. They were more likely to consider the impact on family
life and how they could adapt to it.
Conclusions: Although fathers’ and mothers’ healthcare roles are
similar, they may deal differently with the consequences, and their
emotional and practical support requirements may need to be
addressed differently.
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Background: Recent National Institute for Health and Clinical
Excellence (NICE) guidance has recommended a controversial
reduction in imaging following a urinary tract infection, and
concern has been raised that children with specific renal tract
abnormalities (vesicoureteric reflux in particular) will remain
undiagnosed as a result. Consequently, paediatricians may be
missing opportunities for rapid treatment and appropriate second-
ary prevention.
Aims: To determine whether implementation of NICE guidance
would result in cases of significant renal tract abnormalities being
missed. To compare predicted imaging rates between current local
and NICE guidance.
Methods: A retrospective case note audit of 100 paediatric patients
with a diagnosis of urinary tract infection was performed. Data
were collected on the results of investigations performed under the
local imaging strategy, which pre-dates the latest NICE guidance.
Basic demographic data were used to predict the number of
investigations required under the NICE guidance for the audit
population. The two imaging strategies were compared for each
case, allowing the identification of potentially missed significant
renal abnormalities had NICE guidance been used alone.
Results: 100 patients aged 0–15 years (65% female) were included
in the audit. 27 patients were identified as having a significant renal
abnormality during the investigations performed under the local
imaging strategy. Crucially, eight of these patients had either high-
grade vesicoureteric reflux or renal scarring, which would not have
been detected using NICE guidance alone. Over one quarter of the
159 ultrasound, micturating cystourethrogram (MCUG) and
dimercaptosuccinic acid (DMSA) scans performed on the audit
population demonstrated some form of renal tract abnormality. In
comparison, only 93 scans would have been performed using NICE
guidance, with the most notable reduction occurring in the number
of MCUG being undertaken.
Conclusion: Although NICE guidance reduces the burden of
follow-up investigations, it is clear that a substantial percentage of
children with renal tract abnormalities will either be missed
completely or picked up at a later stage when renal damage has
already occurred.
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The calcium-sensing receptor is thought to be the prime regulator of
parathyroid hormone (PTH) secretion. It is the target of the
calcimimetic drug, cinacalcet, which acts by increasing the
sensitivity of this receptor to extracellular calcium ions, thereby
diminishing PTH secretion.
Aims: To describe the long-term effects of cinacalcet in children
with uncontrolled hyperparathyroidism in the context of end-stage
renal disease. Current literature regarding the use of this drug in
paediatric practice is limited.
Methods: The effects of the calcimimetic drug cinacalcet were
assessed in six children with uncontrolled hyperparathyroidism
secondary to stage 5 chronic kidney disease. Data regarding bone
biochemistry, medications, longitudinal growth and adverse events
were collected over a period of time from the initial commencement
of cinacalcet to the present (July 2007), or earlier if the drug was
discontinued for any reason.
Results: Patients were between the ages of 11 months and 14 years
on commencing cinacalcet at initial doses of 0.4–1.4 mg/kg.
Treatment, which has been well tolerated and is still ongoing in
five of six patients, has been for periods ranging between 3 months
and 3 years, with a maximum dose of 2.6 mg/kg used. Five of six
cases have seen at least an 85% reduction in serum PTH.
Hypophosphataemia and/or hypocalcaemia were observed in three
of six cases. Overall, the achievement of National Kidney Fundation
disease outcomes quality initiative targets was unaffected and there
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